福安药业：公司上市以来开展了系列并购重组，不断发展壮大

Core Viewpoint - Fu'an Pharmaceutical (300194) announced on September 26 that it has engaged in a series of mergers and acquisitions since its listing, continuously growing and expanding. The company aims to leverage its development platform and enhance management practices to achieve excellent results that satisfy investors [1] Group 1 - The company has conducted a series of mergers and acquisitions since its listing [1] - Fu'an Pharmaceutical is committed to utilizing its development platform effectively [1] - The company aims to improve its management practices to deliver satisfactory results to investors [1]